Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.
about
Coenzyme Q10 for heart failureCoenzyme Q10 for heart failureCoenzyme Q10 for the treatment of heart failure: a review of the literatureGlycemic variability and glycemic control in the acutely ill cardiac patientClinical adoption of prognostic biomarkers: the case for heart failureMitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseasesInduction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance to ischemic heart failurePhysiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.Statins and dilated cardiomyopathy: do we have enough data?How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic reviewThe Dynamics of Oxidized LDL during Atherogenesis.Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography.Reactive oxygen species in cardiovascular disease.The role of erythropoietin in myocardial protection: potential mechanisms and applications.Anti-oxidized low-density lipoprotein antibodies in chronic heart failure.Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up studyIncreased presence of oxidized low-density lipoprotein in the left ventricular blood of subjects with cardiovascular disease.The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?New and emerging biomarkers of heart failure.Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease.Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers.Oxidized LDL, LOX-1 and atherosclerosis.New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?MiR-216a: a link between endothelial dysfunction and autophagy.Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way.Oxidized Low-Density Lipoprotein Induces Apoptosis in Cultured Neonatal Rat Cardiomyocytes by Modulating the TLR4/NF-κB Pathway.Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.Ascorbic acid does not affect the age-associated reduction in maximal cardiac output and oxygen consumption in healthy adults.Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.Effect of the Mediterranean diet on heart failure biomarkers: a randomized sample from the PREDIMED trial.Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.Influence of experimental periodontitis on cardiac oxidative stress in rats: a biochemical and histomorphometric study.Oxidative stress in obstructive sleep apnoea.Oxidative stress and nitric oxide synthase in skeletal muscles of rats with post-infarction, compensated chronic heart failure.
P2860
Q24194154-D93699E1-4DE5-4662-B7BE-822ADA54190CQ24235690-0F4D8FC7-87AC-4FB0-A960-66534A3356ACQ26778097-1B85E84F-0E6E-48A1-B9D7-69F1CEE0430AQ26821994-DFFB7CD3-8C7A-414E-90E5-2BABD636595CQ26863716-BF068DD1-A9C9-4D2B-8D55-B3E26A563848Q26866951-D5F2BFC8-DC11-4B29-BEBB-94499DAD3F7AQ28247437-AD04AB5B-8048-40FA-B98A-0FA784EF2870Q33599961-79B3FD5A-902E-4B05-BF9B-8B19A0D11CEDQ33787152-38F43303-BD9E-40CE-80E8-E51C5C653FFFQ33932889-C88706C7-BC25-4EB4-BBF1-FACA29845079Q35024665-43B9E445-F23E-4A3C-A68E-A76065957E90Q35153861-CC00330F-8880-446F-A1BF-36F04A92B6CAQ35165194-78A7FFC7-C78C-433E-9BB5-B75CBA9C46F0Q36352011-39C1036B-AF5C-4E88-9419-FE9738EDF2FCQ36421852-BCC118A9-5F9A-437D-986D-5DBFAFCC59BEQ36487547-6B635F52-2BEC-430D-B853-598521A41443Q36748282-38B268EE-F457-4BB0-9E15-009E8291BE8AQ36811609-A0519CB3-0492-4656-A075-9E413BAC2519Q37275296-7C6E5EBD-4C38-4F13-BC85-1852A30B37B5Q37355913-91883A8B-24DC-4E95-B79A-A46EA914B2F5Q37514230-EA603572-84D8-4233-851D-EA2C5BE2C68EQ37600622-D8B00F92-433D-4EC6-8A92-7EDC6425ABC0Q37705155-896624CB-506F-4DB9-B8E6-F5215EF91B96Q37870921-06F2DAB3-51FA-4CC3-B6F5-A8A4C6463EBDQ37938848-75C14590-C81F-4269-BFF1-84BE53C1D1D6Q38100987-943E9C69-4254-4F5B-A545-82B8F7FF4253Q38299279-6588A812-6328-4152-9938-90F81EFCDA72Q38873521-974CCFFC-27FE-4A65-BC0F-0EB7670CCE58Q40138320-32AFC745-236B-4CAA-B8DC-FF608A8DF942Q41874906-B98BCA25-1324-444D-9C20-490DFFA8D1A2Q42069314-0FD984D1-EE02-46AD-B440-E7B2DB8624E0Q42240864-0B0A06E2-91D9-4DE0-9056-145B7DA9F500Q42638769-ACCFD188-7B71-4533-9CCD-0DC5D50D824FQ43072830-D70F62C6-F199-48C2-A9C5-D67347707857Q43248481-44EDEECD-BDE4-4C08-8445-ADC5923486C1Q43995630-5004CFE3-D74E-449D-BD90-480FC063F9A0Q44805645-1445F798-A6A8-4EBA-B6FF-7D1439EAF726Q46458350-68B1A612-3AB1-4B9C-8C09-289463B7AD90Q46654980-1FBB8219-C647-4180-BA90-B05E044BCC6AQ46747273-6AF1CAF0-7987-4063-8E05-EACFC48A6385
P2860
Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Plasma oxidized low-density li ...... onic congestive heart failure.
@en
Plasma oxidized low-density li ...... onic congestive heart failure.
@nl
type
label
Plasma oxidized low-density li ...... onic congestive heart failure.
@en
Plasma oxidized low-density li ...... onic congestive heart failure.
@nl
prefLabel
Plasma oxidized low-density li ...... onic congestive heart failure.
@en
Plasma oxidized low-density li ...... onic congestive heart failure.
@nl
P2093
P1476
Plasma oxidized low-density li ...... onic congestive heart failure.
@en
P2093
Atsuyuki Wada
Keiko Maeda
Masahiko Kinoshita
Masaru Hayashi
Masato Ohnishi
Naoko Mabuchi
Takashi Tsutsui
Takayoshi Tsutamoto
P304
P356
10.1016/S0735-1097(02)01721-7
P407
P577
2002-03-01T00:00:00Z